[
  {
    "ts": null,
    "headline": "Penumbra (PEN) Down 8% Since Last Earnings Report: Can It Rebound?",
    "summary": "Penumbra (PEN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
    "url": "https://finnhub.io/api/news?id=b965eeb02f51463c356a44d7b8b78a133f862d9fab817eba950609502e0c8e57",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742484637,
      "headline": "Penumbra (PEN) Down 8% Since Last Earnings Report: Can It Rebound?",
      "id": 133326951,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "STE",
      "source": "Yahoo",
      "summary": "Penumbra (PEN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
      "url": "https://finnhub.io/api/news?id=b965eeb02f51463c356a44d7b8b78a133f862d9fab817eba950609502e0c8e57"
    }
  },
  {
    "ts": null,
    "headline": "3 Reasons to Sell STE and 1 Stock to Buy Instead",
    "summary": "STERIS currently trades at $226.40 per share and has shown little upside over the past six months, posting a small loss of 4.5%.",
    "url": "https://finnhub.io/api/news?id=13ab734a5ac0a985b14b352566ac38ce25d8118bd9101540262ba916febcc728",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742461919,
      "headline": "3 Reasons to Sell STE and 1 Stock to Buy Instead",
      "id": 133326952,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "STE",
      "source": "Yahoo",
      "summary": "STERIS currently trades at $226.40 per share and has shown little upside over the past six months, posting a small loss of 4.5%.",
      "url": "https://finnhub.io/api/news?id=13ab734a5ac0a985b14b352566ac38ce25d8118bd9101540262ba916febcc728"
    }
  },
  {
    "ts": null,
    "headline": "Invesco Health Care Fund Q4 2024 Commentary",
    "summary": "Stock selection in life science tools & services, pharmaceuticals and distributors detracted from relative performance, as did an overweight in health care facilities.",
    "url": "https://finnhub.io/api/news?id=8f81827abb6ec00be306ef52a83e31acbe2c243bf3d6f7d992305822a81d2a8e",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742461500,
      "headline": "Invesco Health Care Fund Q4 2024 Commentary",
      "id": 133273550,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2154850841/image_2154850841.jpg?io=getty-c-w1536",
      "related": "STE",
      "source": "SeekingAlpha",
      "summary": "Stock selection in life science tools & services, pharmaceuticals and distributors detracted from relative performance, as did an overweight in health care facilities.",
      "url": "https://finnhub.io/api/news?id=8f81827abb6ec00be306ef52a83e31acbe2c243bf3d6f7d992305822a81d2a8e"
    }
  }
]